166 related articles for article (PubMed ID: 1610223)
1. Myocardial protection of neonatal heart by cardioplegic solution with recombinant human superoxide dismutase.
Tatebe S; Nakazawa M; Miyamura H; Hayashi J; Eguchi S; Imai S
Ann Thorac Surg; 1992 Jul; 54(1):124-9. PubMed ID: 1610223
[TBL] [Abstract][Full Text] [Related]
2. Interactions between preischemic hypothermia and cardioplegic solutions in the neonatal lamb heart.
Aoki M; Nomura F; Mayer JE
J Thorac Cardiovasc Surg; 1994 Mar; 107(3):822-8. PubMed ID: 8127111
[TBL] [Abstract][Full Text] [Related]
3. Transient hypocalcemic reperfusion does not improve postischemic recovery in the rat heart after preservation with St. Thomas' Hospital cardioplegic solution.
Chambers DJ; Harvey DM; Braimbridge MV; Hearse DJ
J Thorac Cardiovasc Surg; 1992 Aug; 104(2):344-56. PubMed ID: 1495296
[TBL] [Abstract][Full Text] [Related]
4. Effect of sodium aspartate on the recovery of the rat heart from long-term hypothermic storage.
Galiñanes M; Chambers DJ; Hearse DJ
J Thorac Cardiovasc Surg; 1992 Mar; 103(3):521-31. PubMed ID: 1545551
[TBL] [Abstract][Full Text] [Related]
5. High cardioplegic perfusion pressure entails reduced myocardial recovery.
Irtun O; Sørlie D
Eur J Cardiothorac Surg; 1997 Feb; 11(2):358-62. PubMed ID: 9080168
[TBL] [Abstract][Full Text] [Related]
6. Myocardial protection with potassium-channel openers is as effective as St. Thomas' solution in the rabbit heart.
Lawton JS; Sepic JD; Allen CT; Hsia PW; Damiano RJ
Ann Thorac Surg; 1996 Jul; 62(1):31-8; discussion 38-9. PubMed ID: 8678673
[TBL] [Abstract][Full Text] [Related]
7. Cardioplegia and vascular injury. Dissociation of the effects of ischemia from those of the cardioplegic solution.
Saldanha C; Hearse DJ
J Thorac Cardiovasc Surg; 1994 Aug; 108(2):279-90. PubMed ID: 8041176
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of University of Wisconsin solution on prolonged myocardial protection as assessed by phosphorus 31-nuclear magnetic resonance spectroscopy and functional recovery.
Karck M; Vivi A; Tassini M; Schwalb H; Askenasy N; Navon G; Borman JB; Uretzky G
J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1356-64. PubMed ID: 1434717
[TBL] [Abstract][Full Text] [Related]
9. Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart.
Kempsford RD; Hearse DJ
J Thorac Cardiovasc Surg; 1989 Jun; 97(6):856-63. PubMed ID: 2498580
[TBL] [Abstract][Full Text] [Related]
10. Developmental differences in myocardial protection in response to 5'-nucleotidase inhibition.
Pridjian AK; Bove EL; Bolling SF; Childs KF; Brosamer KM; Lupinetti FM
J Thorac Cardiovasc Surg; 1994 Feb; 107(2):520-6. PubMed ID: 8302072
[TBL] [Abstract][Full Text] [Related]
11. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution.
Yang SS; Hearse DJ
Can J Cardiol; 1989; 5(8):401-7. PubMed ID: 2514036
[TBL] [Abstract][Full Text] [Related]
12. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
Bessho R; Chambers DJ
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of myocardial protective effects between GIK solution and St. Thomas solution by use of canine isolated heart-lung preparations].
Ina H; Yasuda I
Nihon Kyobu Geka Gakkai Zasshi; 1989 Nov; 37(11):2318-27. PubMed ID: 2693545
[TBL] [Abstract][Full Text] [Related]
14. The immature and the mature myocardium. Responses to multidose crystalloid cardioplegia.
Magovern JA; Pae WE; Miller CA; Waldhausen JA
J Thorac Cardiovasc Surg; 1988 Apr; 95(4):618-24. PubMed ID: 3352295
[TBL] [Abstract][Full Text] [Related]
15. Low-potassium University of Wisconsin solution for cardioplegia: improved protection of the isolated ischemic neonatal rabbit heart.
Uesaka T; Chiba Y; Ihaya A; Nara M; Niwa H; Muraoka R
Cardiovasc Surg; 1999 Dec; 7(7):723-9. PubMed ID: 10639047
[TBL] [Abstract][Full Text] [Related]
16. Advantages of continuous hyperpolarized arrest with pinacidil over St. Thomas' Hospital solution during prolonged ischemia.
Jayawant M; Stephenson ER; Damiano RJ
J Thorac Cardiovasc Surg; 1998 Jul; 116(1):131-8. PubMed ID: 9671907
[TBL] [Abstract][Full Text] [Related]
17. Species differences in susceptibility to ischemic injury and responsiveness to myocardial protection.
Galiñanes M; Hearse DJ
Cardioscience; 1990 Jun; 1(2):127-43. PubMed ID: 2102801
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of crystalloid cardioplegic protection against global normothermic ischemia by superoxide dismutase plus catalase but not diltiazem in the isolated, working rat heart.
Greenfield DT; Greenfield LJ; Hess ML
J Thorac Cardiovasc Surg; 1988 May; 95(5):799-813. PubMed ID: 3361928
[TBL] [Abstract][Full Text] [Related]
19. [Effects of cardioplegic solutions on coronary artery and myocardium--comparison of the glucose-insulin-potassium solution and the St. Thomas' Hospital cardioplegic solution].
Watanabe H; Yokosawa T; Eguchi S; Imai S
Nihon Kyobu Geka Gakkai Zasshi; 1989 Oct; 37(10):2142-9. PubMed ID: 2685132
[TBL] [Abstract][Full Text] [Related]
20. The role of isocolloidoosmotic synthetic colloid addition to St. Thomas Hospital cardioplegic solution for cardioprotection in isolated perfused rat hearts.
Süzer O; Diri E; Konukoğlu D; Ozüner Z
Pharmacol Res; 1997 Jul; 36(1):9-15. PubMed ID: 9368909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
